Key result
The 1-km treadmill test accurately predicts VO2peak changes after walking training compared to CPX.
Why the study?
To determine whether the moderate 1-km treadmill walking test can predict changes in peak oxygen uptake in patients with stable cardiovascular disease during an exercise-based secondary prevention program.
Does the moderate 1-km treadmill walking test accurately predict changes in peak oxygen uptake after an 8-week walking training program in male outpatients with stable cardiovascular disease?
Observational (n=64)
Does the moderate 1-km treadmill walking test accurately predict changes in peak oxygen uptake after an 8-week walking training program in male outpatients with stable cardiovascular disease?
Effect estimate: mean difference -0.3 mL/kg/min
p-value: p=>.05
The 1-km treadmill walking test provides a reasonably accurate and simple tool to predict changes in peak oxygen uptake due to moderate walking training in male outpatients with cardiovascular disease.
Supports the 1-km test for monitoring VO2peak changes in stable male CVD outpatients; hypothesis-generating and requires larger prospective validation.
PURPOSE: The purpose of this study was to determine the ability of the moderate 1-km treadmill walking test (1km-TWT) to predict changes in peak oxygen uptake (V˙O 2peak ) in patients with stable cardiovascular disease (CVD) during an exercise-based secondary prevention program. METHODS: Sixty-four male outpatients with stable CVD (age 64 [41-85] yr) performed the 1km-TWT before and after an 8-wk walking training program. Patient V˙O 2peak was estimated using a sex-specific equation including age, body mass index, 1km-TWT performance time, and heart rate (V˙O 2peakEST ). Forty-one patients completed a maximal cardiopulmonary treadmill test (CPX) for direct V˙O 2peak determination (V˙O 2peakMEAS ). The training prescription consisted of moderate-to-high intensity supervised walking for 30-40 min/session, and an additional 2-4 times/wk of unsupervised home moderate walking sessions between 20-60 min at the end of the program. The walking intensity was based on the results of the 1km-TWT. RESULTS: Patients participated in an average of 14 of the 16 supervised sessions. An overall significant improvement in V˙O 2peakMEAS and weekly recreational physical activity levels were observed. No differences were observed between V˙O 2peakMEAS and V˙O 2peakEST . Compared with CPX results, the 1km-TWT underestimated the V˙O 2peak increase after the exercise intervention (mean difference -0.3 mL/kg/min, P > .05). CONCLUSIONS: The 1km-TWT provides a reasonably accurate and simple tool to predict changes in V˙O 2peak due to moderate walking training in male outpatients with CVD. These findings contribute to the growing body of evidence supporting the use of the 1km-TWT for exercise testing and training purposes in the context of cardiac rehabilitation/secondary prevention programs.
No takes yet. Share an insight, caveat, or question.
Raisi et al. (2023) conducted an observational in stable cardiovascular disease (n=64). 1-km treadmill walking test (1km-TWT) vs. maximal cardiopulmonary treadmill test (CPX) was evaluated on change in peak oxygen uptake (VO2peak) (mean difference -0.3 mL/kg/min, p=>.05). The 1-km treadmill walking test accurately predicted changes in peak oxygen uptake after an 8-week walking training program compared to CPX (mean difference -0.3 mL/kg/min, P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: